Scinai Immunotherapeutics (SCNI) Other Working Capital Changes (2021 - 2026)
Scinai Immunotherapeutics (SCNI) reported Other Working Capital Changes of -$78000.0 for Q1 2026, up 7.14% on a YoY basis from -$72800.0 in Q1 2025, and down 124.3% sequentially from $321000.0 in Q2 2025.
Scinai Immunotherapeutics (SCNI) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 8 years of Other Working Capital Changes data on file, last reported at -$78000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 7.14% year-over-year to -$78000.0; the trailing twelve-month figure through Mar 2026 stood at $91000.0 (up 128.09% YoY), and the FY2025 full-year result was $147000.0, up 146.82% from the prior year.
- Other Working Capital Changes declined to -$78000.0 in Q1 2026, from $321000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $114000.0 in Q2 2024 to a low of -$530000.0 in Q4 2024.
- A 5-year average of -$27750.0 and a median of $2000.0 in 2023 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes sank 2775.0% in 2024 and jumped 379.13% in 2025, its largest moves.
- Tracing SCNI's Other Working Capital Changes over 5 years: stood at -$166000.0 in 2022, then soared by 97.59% to -$4000.0 in 2023, then slumped by 1600.0% to -$68000.0 in 2024, then jumped by 572.06% to $321000.0 in 2025, then plunged by 124.3% to -$78000.0 in 2026.
- Business Quant data shows SCNI's Other Working Capital Changes at -$78000.0 in Q1 2026, $321000.0 in Q2 2025, and -$84000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106,000.00 |
| Mar 31, 2026 | 106,000.00 |
| Mar 31, 2026 | 106,000.00 |
| Jun 30, 2025 | -39,000.00 |
| Jun 30, 2025 | -39,000.00 |
| Jun 30, 2025 | -39,000.00 |
| Mar 31, 2025 | 70,000.00 |
| Mar 31, 2025 | 70,000.00 |
| Mar 31, 2025 | 70,000.00 |
| Dec 31, 2024 | -530,000.00 |
| Dec 31, 2024 | -530,000.00 |
| Dec 31, 2024 | -530,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Jun 30, 2024 | 114,000.00 |
| Jun 30, 2024 | 114,000.00 |
| Jun 30, 2024 | 114,000.00 |
| Mar 31, 2024 | 75,000.00 |
| Mar 31, 2024 | 75,000.00 |